ACE inhibitors: back to prime time?

Editorial

Milan Gupta et al. Heart. 2007 Sep.

. 2007 Sep;93(9):1015-6.

doi: 10.1136/hrt.2006.108100.

Abstract

See articles on pages 1026 and 1081

Conflict of interest: None declared.

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.
Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Deckers J, Ferrari R, Remme WJ, Bertrand M, Fox K; EUROPA Trial Investigators. Briggs A, et al. Heart. 2007 Sep;93(9):1081-6. doi: 10.1136/hrt.2005.086728. Epub 2006 Nov 29. Heart. 2007. PMID: 17135223 Free PMC article. Clinical Trial.

1. Pfeffer M A, Braunwald E, Moye L A.et al Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992327669–677. - PubMed
1. The SOLVD investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991325293–302. - PubMed
1. The Acute Infarction Ramipril Efficacy (AIRE) Study investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993342821–828. - PubMed
1. Torp‐Pedersen C, Kober L for the TRACE Study Group Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left‐ventricular function after acute myocardial infarction. Lancet 19993549–12. - PubMed
1. Yusuf S, Pepine C J, Garces C.et al Effects of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 19923401173–1178. - PubMed